These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 19100300

  • 1. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A, Lurje G, Manegold PC, Lenz HJ.
    Adv Drug Deliv Rev; 2009 May 20; 61(5):375-80. PubMed ID: 19100300
    [Abstract] [Full Text] [Related]

  • 2. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM, Labonte MJ, Lenz HJ.
    Cancer J; 2010 May 20; 16(3):262-72. PubMed ID: 20526105
    [Abstract] [Full Text] [Related]

  • 3. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.
    Tejpar S.
    Best Pract Res Clin Gastroenterol; 2007 May 20; 21(6):1071-87. PubMed ID: 18070704
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment.
    Pasche B, Mulcahy M, Benson AB.
    Best Pract Res Clin Gastroenterol; 2002 Apr 20; 16(2):331-45. PubMed ID: 11969242
    [Abstract] [Full Text] [Related]

  • 11. Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
    Graziano F, Catalano V, Baldelli AM, Cascinu S.
    Expert Rev Anticancer Ther; 2001 Aug 20; 1(2):247-57. PubMed ID: 12113030
    [Abstract] [Full Text] [Related]

  • 12. Predictive markers for colorectal cancer: current status and future prospects.
    Longley DB, McDermott U, Johnston PG.
    Clin Colorectal Cancer; 2003 Feb 20; 2(4):223-30. PubMed ID: 12620141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
    Kruzelock RP, Short W.
    Curr Probl Cancer; 2007 Feb 20; 31(5):315-66. PubMed ID: 17905192
    [No Abstract] [Full Text] [Related]

  • 17. Predictive factors for response to chemotherapy in colorectal cancer patients.
    Vincenzi B, Cesa AL, Santini D, Schiavon G, Grilli C, Graziano F, Tonini G.
    Crit Rev Oncol Hematol; 2004 Oct 20; 52(1):45-60. PubMed ID: 15363466
    [Abstract] [Full Text] [Related]

  • 18. Pharmacogenetics in chemotherapy of colorectal cancer.
    Henriette Tanja L, Guchelaar HJ, Gelderblom H.
    Best Pract Res Clin Gastroenterol; 2009 Oct 20; 23(2):257-73. PubMed ID: 19414151
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
    Russo A, Corsale S, Cammareri P, Agnese V, Cascio S, Di Fede G, Macaluso M, Bazan V.
    J Cell Physiol; 2005 Sep 20; 204(3):742-9. PubMed ID: 15828025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.